Timing and space usage are disrupted by amphetamine in rats maintained on DRL 24-s and DRL 72-s schedules of reinforcement
dc.contributor.author | Fowler, Stephen C. | |
dc.contributor.author | Pinkston, Jonathan W. | |
dc.contributor.author | Vorontsova, Elena | |
dc.date.accessioned | 2017-06-28T20:00:54Z | |
dc.date.available | 2017-06-28T20:00:54Z | |
dc.date.issued | 2009-06 | |
dc.identifier.citation | Fowler, S. C., Pinkston, J., & Vorontsova, E. (2009). Timing and space usage are disrupted by amphetamine in rats maintained on DRL 24-s and DRL 72-s schedules of reinforcement. Psychopharmacology, 204(2), 213–225. http://doi.org/10.1007/s00213-008-1451-x | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/24691 | |
dc.description.abstract | RATIONALE: A differential-reinforcement-of-low-rate schedule (DRL) delivers reinforcement only when the interresponse time (IRT) exceeds a fixed time interval, thereby shaping rats to discriminate the timing of their responses. However, little is known about the motor behavior and location of the rats in the chamber during the IRTs that lead to reinforcement. Although amphetamine is known to disrupt DRL timing behavior, the effects of this drug on non-operant motor behavior during DRL performance has not yet been quantified. OBJECTIVE: The purpose of this research was to measure the motor behavior (movement trajectories in the horizontal plane and spatial location in the plane) during longer IRT’s after either vehicle or amphetamine treatment. METHOD: Experimental chambers were constructed with a force-plate actometer as the floor, and while performing the operant task, the rats’ motor behaviors were measured continuously with high temporal and spatial resolution. Separate groups of 8 male Sprague Dawley rats were maintained on either DRL 24-s or DRL 72-s schedules of water reinforcement in 4-hr recording sessions. RESULTS: Analyses of IRT distributions showed that the rats’ timing behavior conformed to their respective DRL requirements. In the absence of drug, analysis of motor behavior in pre-reinforcement intervals showed that rats located themselves away from the operandum, and exhibited very low levels of movement. Rats exhibited a significant temporal diminution of horizontal movement that reached a minimum 4–8 s before the rats moved to the operandum to execute operant responses. Amphetamine treatment increased locomotion, abolished the temporal movement gradient, and brought the rats closer to the operandum compared to vehicle treatment. Movement changes induced by amphetamine were accompanied by degraded timing behavior. CONCLUSIONS: Taken together, the data show that DRL training induced rats to locate themselves away from the operandum and to remain nearly motionless during longer IRTs, and that amphetamine treatment interfered with this complex of behavioral features. | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 4.0 (CC BY-NC-ND 4.0), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | en_US |
dc.subject | Differential reinforcement of low rate | en_US |
dc.subject | DRL 72 s | en_US |
dc.subject | D-amphetamine | en_US |
dc.subject | Temporal discrimination | en_US |
dc.subject | Focused stereotypy | en_US |
dc.subject | Sensitization | en_US |
dc.subject | Force-plate actometer | en_US |
dc.subject | Rat | en_US |
dc.title | Timing and space usage are disrupted by amphetamine in rats maintained on DRL 24-s and DRL 72-s schedules of reinforcement | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Fowler, Stephen C. | |
kusw.kudepartment | Pharmacy | en_US |
kusw.oanotes | Per SHERPA/RoMEO 6/28/2017: Author's Pre-print: green tick author can archive pre-print (ie pre-refereeing) Author's Post-print: green tick author can archive post-print (ie final draft post-refereeing) Publisher's Version/PDF: cross author cannot archive publisher's version/PDF General Conditions: Authors pre-print on any website, including arXiv and RePEC Author's post-print on author's personal website immediately Author's post-print on open access repository after an embargo period of between 12 months and 48 months Permitted deposit due to Funding Body, Institutional and Governmental policy or mandate, may be required to comply with embargo periods of 12 months to 48 months Author's post-print may be used to update arXiv and RepEC Publisher's version/PDF cannot be used Must link to publisher version with DOI Author's post-print must be released with a Creative Commons Attribution Non-Commercial No Derivatives License | en_US |
dc.identifier.doi | 10.1007/s00213-008-1451-x | en_US |
kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.identifier.pmid | PMC3708684 | en_US |
dc.rights.accessrights | openAccess |
Files in this item
This item appears in the following Collection(s)
-
Pharmacy Scholarly Works [293]
Except where otherwise noted, this item's license is described as: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 4.0 (CC BY-NC-ND 4.0), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.